NU
NUOX
NuvOx Therapeutics, Inc.—
Filing reports
2
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 1/2
Price
Daily candles with volume.
No data for this timeframe.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 9, 2026 SEC Sep 16, 2026 SEC
NuvOx Therapeutics filed Amendment No. 2 to its S-1 registration statement for an IPO of 2,860,000 shares at an…
S-1/A — Impact 5/10
NuvOx Therapeutics filed Amendment No. 1 to its S-1 registration statement for an IPO of 2,860,000 shares of common…
S-1/A — Impact 5/10
SecBot reports
2 filings · 0 bullish · 0 bearish · 2 neutral- NEUTRAL S-1/AOct 9, 2026
NuvOx Therapeutics filed Amendment No. 2 to its S-1 registration statement for an IPO of 2,860,000…
NuvOx Therapeutics filed Amendment No. 2 to its S-1 registration statement for an IPO of 2,860,000 shares at an estimated $6.00-$8.00 per share, seeking a NYSE American listing under 'NUOX'. The…
- NEUTRAL S-1/ASep 16, 2026
NuvOx Therapeutics filed Amendment No. 1 to its S-1 registration statement for an IPO of 2,860,000…
The IPO is a binary event for NuvOx — without it, the company faces imminent cash depletion and potential failure. Monitor the final pricing and upsized demand; post-IPO, the key catalysts are the…
All NUOX filing & press-release reports (2)
- S-1/A reportOct 9, 2026
- S-1/A reportSep 16, 2026